Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
---|
04/12/2001 | WO2001025189A1 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds |
04/12/2001 | WO2001025181A1 Carboxylic acid derivatives and drugs containing the same |
04/12/2001 | WO2001024828A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
04/12/2001 | WO2001024827A2 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
04/12/2001 | WO2001024786A1 Preventive or therapeutic drugs for diabetes |
04/12/2001 | WO1999057117A3 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
04/12/2001 | DE19948269A1 New compounds as integrin antagonists useful for treating e.g. cardiovascular disorders, rheumatoid arthritis, kidney failure, stroke, cancer, osteoporosis, psoriasis or infection |
04/12/2001 | DE19948101A1 New substituted aryl- and heteroaryl-alkanes are serine protease and thrombin inhibitors, used for treatment of e.g. deep vein thrombosis or stroke |
04/12/2001 | CA2386457A1 Inhibitors of the endothelin signalling pathway and .alpha.v.beta.3 integrin receptor antagonists for combination therapy |
04/12/2001 | CA2386373A1 Method for improving the solubility of tricyclic amino alcohol derivatives |
04/12/2001 | CA2385972A1 Novel diarylamide derivatives and use thereof as medicines |
04/12/2001 | CA2372715A1 Preventive or therapeutic drugs for diabetes |
04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
04/11/2001 | EP1090908A2 Cyclobutane derivatives as inhibitors of protein farnesyltransferase |
04/11/2001 | EP1089966A1 Novel compounds useful in pain management |
04/11/2001 | EP1089964A1 Hydrazine derivatives |
04/11/2001 | EP1089963A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
04/11/2001 | CN1291100A Cyclopentane Heptan (ene) oic acid, 2-hetero arylakenyl derivatives and therapeutic agents |
04/11/2001 | CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives |
04/11/2001 | CN1064349C Novel tricyclic amide, its preparing method and medicinal composition |
04/10/2001 | US6215016 Hematopoietic agents; preventing cytopenia |
04/10/2001 | US6215005 (2-(2-thienyl)ethylamino)(2-halophenyl)acetonitrile; reacting alkali metal cyanide, o-halobenzaldehyde and 2-(2-thienyl)-ethylamine; cyanation, reduction, alkylation, amination |
04/10/2001 | US6214994 Treatment of neoplastic diseases, bacterial or fungal infections, and preventing or decreasing production of phosphorylated paired helical filament (phf) epitopes associated with alzheimer's disease |
04/10/2001 | US6214883 Benzamidoxime prodrugs as antipneumocystic agents |
04/10/2001 | US6214877 Antidiabetic agents; modulator of glucose concentration |
04/10/2001 | US6214859 Psychological disorders; alzheimer's disorders; parkinson'sdisorders |
04/10/2001 | US6214835 Dihalopropene compounds insecticides containing them as active ingredients, and intermediates for their production |
04/10/2001 | US6214481 Organic blue-emitting layer sandwiched between two electrodes |
04/07/2001 | CA2285578A1 Rhodium-catalyzed addition of alkenyl- and aryltrifluoroborates to aldehydes and enones |
04/05/2001 | WO2001023496A1 Organic electroluminescent element |
04/05/2001 | WO2001023379A1 Pharmaceutically active sulfonyl amino acid derivatives |
04/05/2001 | WO2001023378A1 Pharmaceutically active sulfonamide derivatives |
04/05/2001 | WO2001023375A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
04/05/2001 | WO2001023369A2 Process for preparing benzoic acids |
04/05/2001 | WO2001023352A2 Preparation of sulfonyl imine compounds |
04/05/2001 | WO2001023350A1 Thioalkylamine derivatives and process for the preparation thereof |
04/05/2001 | WO2001023347A1 Novel aromatic compounds |
04/05/2001 | WO2000059897A3 Esters and carbonates of 2-(4-hydroxyphenyl)-6(or 5)-hydroxy-benzothiophene derivatives as selective estrogenic compounds |
04/05/2001 | DE19947457A1 New 2'-aminomethyl-biphenyl-2-carboxamide derivatives, are potassium channel blockers especially useful for treating re-entry or supraventricular arrhythmia or atrial fibrillation or flutter |
04/05/2001 | CA2384997A1 Pharmaceutically active sulfonyl amino acid derivatives |
04/05/2001 | CA2378028A1 Preparation of sulfonyl imine compounds |
04/04/2001 | EP1088842A1 Optically active polythiophene |
04/04/2001 | EP1088821A1 Pharmaceutically active sulfonamide derivatives |
04/04/2001 | EP1088815A1 Pharmaceutically active sulfonyl amino acid derivatives |
04/04/2001 | EP1087941A2 Thiolesters and uses thereof |
04/04/2001 | EP1087939A1 Process for preparation of pyrimidinone derivatives |
04/04/2001 | EP1087934A1 Aminocyclohexyl ether compounds and uses thereof |
04/04/2001 | EP0748803B1 Process for producing carboxylic acid derivative |
04/04/2001 | CN1290247A Process and intermediates useful to make antifolates |
04/04/2001 | CN1290164A Inhibition of RAF kinase using substituted heterocyclic ureas |
04/04/2001 | CN1064041C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for production of pharmaceutical preparations, and pharmaceutical preparations containing them |
04/03/2001 | US6211364 Process for preparing indane-like compounds |
04/03/2001 | US6211245 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
04/03/2001 | US6211240 O-benzyl oxime ether derivatives and their use as pesticides |
04/03/2001 | US6211234 Substituted phenyl compounds |
04/03/2001 | US6211197 Carboxylic acid or tetrazole derivates; analgesics, antipyretics, and antiinflammatory agents; side effect reduction |
04/03/2001 | US6211178 Antiprotozoa agents for coccidioides; cyclization |
03/29/2001 | WO2001021606A1 Liquid crystal compounds |
03/29/2001 | WO2001021604A1 Substituted piperazine derivatives, the production thereof and their use as inhibitors of the microsomal triglyceride-transfer protein (mtp) |
03/29/2001 | WO2001021584A1 Tyrosine derivatives |
03/29/2001 | WO2001021583A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
03/29/2001 | WO2001021577A2 Melanin concentrating hormone antagonist |
03/29/2001 | WO2001021160A2 Carboxymide and aniline derivatives as selective inhibitors of pathogens |
03/29/2001 | WO2001002350A3 Novel amino sulfonamides and amido sulfonamides as antiviral agents |
03/29/2001 | WO2000061232A3 Methods and compositions for the treatment and prevention of lung disease involving a specific rar-beta antagonist |
03/29/2001 | WO2000059875A3 Novel inhibitors of formation of advanced glycation endproducts (age's) |
03/29/2001 | DE19945594A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments |
03/29/2001 | CA2386474A1 Melanin concentrating hormone antagonist |
03/28/2001 | EP1086098A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
03/28/2001 | EP1086091A1 Hiv integrase inhibitors |
03/28/2001 | EP1035772A4 Fungicidal compositions and methods, and compounds and methods for the preparation thereof |
03/28/2001 | CN1289321A Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
03/28/2001 | CN1289248A Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
03/27/2001 | US6208719 Method and apparatus for telecommunications having automatic network adaptations and silent mode operations |
03/27/2001 | US6207701 Urokinase inhibitors |
03/27/2001 | US6207698 For therapy of osteoarthritis, rheumatoid arthritis, corneal ulceration, periodontitis, metastasis and invasion of tumor, and virus infection |
03/27/2001 | US6207685 Inhibiting effects of exogenous neurotoxic or neurotoxinic products in warm-blooded animals by administering 2-methyl-1-(1-piperidinyl)-1-(2-thienyl)-cyclohexane in pure racemic, diastereoisomeric or enantiomeric form |
03/22/2001 | WO2001019821A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |
03/22/2001 | WO2001019814A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
03/22/2001 | WO2001019811A2 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv |
03/22/2001 | WO2001019809A1 Tryptase inhibitors |
03/22/2001 | WO2001019808A1 Chemical compounds and compositions and their use as cathepsin s inhibitors |
03/22/2001 | WO2001019798A2 INHIBITORS OF FACTOR Xa |
03/22/2001 | WO2001019796A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
03/22/2001 | WO2001019788A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
03/22/2001 | WO2001019780A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
03/22/2001 | WO2001019778A1 Novel dicarboxylic acid derivatives with pharmaceutical properties |
03/22/2001 | WO2001019770A2 Rxr modulators with improved pharmacologic profile |
03/22/2001 | WO2000040576A3 Thiopyran compounds as inhibitors of mmp |
03/22/2001 | WO2000035435A9 Use of a mek inhibitor for preventing transplant rejection |
03/22/2001 | DE10036855A1 Neue kristalline Form von 6-Hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophenhydrochlorid New crystalline form of 6-hydroxy-3- (4- [2- (piperidin-1-yl) ethoxy] phenoxy) -2- (4-methoxyphenyl) benzo [b] thiophene hydrochloride |
03/22/2001 | CA2385589A1 Inhibitors of factor xa |
03/22/2001 | CA2384974A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
03/22/2001 | CA2384783A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
03/22/2001 | CA2384763A1 Tryptase inhibitors |
03/22/2001 | CA2383565A1 Rxr modulators with improved pharmacologic profile |
03/21/2001 | EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents |
03/21/2001 | EP1085009A1 Indan derivatives |
03/21/2001 | EP1084711A1 Remedies for itching containing pgd 2? antagonists |